Benzinga | Nov 5, 2020 05:04PM EST

Dicerna Pharmaceuticals Q3 EPS $(0.29) Misses $(0.20) Estimate, Sales $48.88M Miss $51.50M Estimate

Dicerna Pharmaceuticals (NASDAQ:DRNA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.20) by 45 percent. This is a 35.56 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $48.88 million which missed the analyst consensus estimate of $51.50 million by 5.10 percent. This is a 508.28 percent increase over sales of $8.04 million the same period last year.